Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Molecular Medicine (Berlin, Germany)|September 9, 2021
Circulating circRNA as biomarkers for dilated cardiomyopathy etiologyMarina C Costa, Maria Calderon-Dominguez, Alipio Mangas, et al.Journal of Clinical Medicine|March 14, 2026
Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary SyndromeNelsa González-Aguado, Rafael Franco-Hita, Jose Ignacio Larrubia-Valle, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 31, 2025
Effects of sacubitril/valsartan on cardiac remodeling in heart failure with reduced ejection fraction: An integrated study of molecular biomarkers and imaging techniquesAinhoa Robles-Mezcua, James L Januzzi, Francisco Javier Pavón-Morón, et al.European Journal of Heart Failure|May 23, 2022
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trialPatricia Palau, Martina Amiguet, Eloy Domínguez, et al.European Heart Journal. Cardiovascular Imaging|August 10, 2023
Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlationFernando de Frutos, Juan Pablo Ochoa, Ana Isabel Fernández, et al.European Heart Journal|August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failureDouglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.Circulation. Heart Failure|September 23, 2020
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN GeneMohammed Majid Akhtar, Massimiliano Lorenzini, Marcos Cicerchia, et al.Revista Espanola De Cardiologia (English Ed.)|July 4, 2020
Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registryRoberto Barriales-Villa, Juan P Ochoa, José M Larrañaga-Moreira, et al.Journal of the American College of Cardiology|October 22, 2021
Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated CardiomyopathyLuis Escobar-Lopez, Juan Pablo Ochoa, Jesús G Mirelis, et al.European Heart Journal|August 29, 2025
Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failureNerea Mora-Ayestarán, Juan Pablo Ochoa, Cristina Gómez-González, et al.Pageof 3